An accomplished pharmaceutical executive who heads Cambridge Therapeutics, John Klein has received the Ellis Island Medal of Honor and Business Week’s Corporate Turnaround of the Year recognition, in addition to earning 11th place on Forbes’ list of Top 100 CEOs. As chairman and CEO of Cambridge Therapeutics, John Klein oversees all strategic planning in relation to the distribution of drugs and combination therapies to patients around the nation. Prior to creating this company in 2011, he developed Dava Pharmaceutical Company from the ground up and also headed Ivax Pharmaceutical and Zenith Laboratories, Inc. He additionally chaired the Worldwide Generics Pharmaceutical Industry Association.
Involved in his local community, he serves as a trustee of Hackensack Meridian Health Hospitals, as well as of the Dwight-Englewood School. Formerly, he served as president of the board at this college preparatory academy.
He holds an MBA in in finance from Roosevelt University and also completed coursework on executive decision-making in relation to marketing at the Wharton School of the University of Pennsylvania.